DOW
58
-5
ROK
44
-7
KEY
51
-3
ESS
60
-8
DGX
39
-4
PCG
80
3
AVB
65
-2
MTCH
44
-4
BBY
56
-2
CMS
67
3
DUK
64
2
GME
63
12
AVY
53
-9
SBUX
41
-3
WMB
60
4
PGR
68
3
SO
66
2
NRG
69
12
IFF
56
-3
DOV
64
-5
DOW
58
-5
ROK
44
-7
KEY
51
-3
ESS
60
-8
DGX
39
-4
PCG
80
3
AVB
65
-2
MTCH
44
-4
BBY
56
-2
CMS
67
3
DUK
64
2
GME
63
12
AVY
53
-9
SBUX
41
-3
WMB
60
4
PGR
68
3
SO
66
2
NRG
69
12
IFF
56
-3
DOV
64
-5
Financhill
Back

Duos Technologies Group Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
46

DUOT
Duos Technologies Group

Last Price:
2.45
Seasonality Move:
-24.56%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
46
Duos Technologies Group (DUOT) is a Sell

Is Duos Technologies Group a Buy, Sell or Hold?

  • The current Duos Technologies Group [DUOT] share price is $2.42. The Score for DUOT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • DUOT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

DUOT Stock Price Chart

What is Duos Technologies Group's stock price today?

  • The Duos Technologies Group share price today is $2.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DUOT is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

DUOT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 46.03 Sell
Chaikin Money Flow: -20231 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.33 - 2.57) Sell
Bollinger Bands (100): (2.39 - 2.93) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

DUOT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.52 Sell
20-day SMA: 2.43 Sell
50-day SMA: 2.62 Sell
200-day SMA: 3.11 Sell
8-day EMA: 2.52 Sell
20-day EMA: 2.49 Sell
50-day EMA: 2.57 Sell
200-day EMA: 3.1 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Duos Technologies Group Earnings Growth & DUOT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.16 per share, an increase this year of $0.22 per share, and an increase next year of $0.87 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Duos Technologies Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):